HAE Anila Lingamneni sells $192K worth of shares
Jul 15, 2024, 8:32 PM
-18.77%
What does HAE do
Haemonetics Corp., headquartered in Boston, Massachusetts, develops and distributes hematology products, serving blood and plasma collection, surgical, and hospital transfusion markets with 3,034 employees. The company's offerings include automated systems, donor software, and solutions enhancing patient care and reducing healthcare costs across its Plasma, Blood Center, and Hospital segments.
Anila Lingamneni sold 2,136 shares of HAE on 11 July at $90.00 per share, worth a total of $192K. They now own 21,410 HAE shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.